Multicenter evaluation of left ventricular assist device implantation with or without ECMO bridge in cardiogenic shock
Artificial Organs · 2024-08 · 48 (8) · 921-931
DOI: 10.1111/aor.14740 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Artificial Organs, online erschienen am 08.03.2024. Verfasst von James W Schurr und 15 weiteren Autor:innen. Beteiligte Einrichtung: Hospital of the University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Extracorporeal Membrane Oxygenation, Heart-Assist Devices, Shock, Cardiogenic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
The efficacy of extracorporeal membrane oxygenation (ECMO) as a bridge to left ventricular assist device (LVAD) remains unclear, and recipients of the more contemporary HeartMate 3 (HM3) LVAD are not well represented in previous studies. We therefore undertook a multicenter, retrospective study of this population. Methods and Results INTERMACS 1 LVAD recipients from five U.S. centers were included. In‐hospital and one‐year outcomes were recorded. The primary outcome was the overall mortality hazard comparing ECMO versus non‐ECMO patients by propensity‐weighted survival analysis. Secondary outcomes included survival by LVAD type, as well as postoperative and one‐year outcomes. One hundred and twenty‐seven patients were included; 24 received ECMO as a bridge to LVAD. Mortality was higher in patients bridged with ECMO in the primary analysis (HR 3.22 [95%CI 1.06–9.77], p = 0.039). Right ventricular assist device was more common in the ECMO group (ECMO: 54.2% vs non‐ECMO: 11.7%, p < 0.001). Ischemic stroke was higher at one year in the ECMO group (ECMO: 25.0% vs non‐ECMO: 4.9%, p = 0.006). Among the study cohort, one‐year mortality was lower in HM3 than in HeartMate II (HMII) or HeartWare HVAD (10.5% vs 46.9% vs 31.6%, respectively; p < 0.001) recipients. Pump thrombosis at one year was lower in HM3 than in HMII or HVAD (1.8% vs 16.1% vs 16.2%, respectively; p = 0.026) recipients.
Conclusions
Higher mortality was observed with ECMO as a bridge to LVAD, likely due to higher acuity illness, yet acceptable one‐year survival was seen compared with historical rates. The receipt of the HM3 was associated with improved survival compared with older generation devices.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hospital of the University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
- Johns Hopkins Hospital, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
- Stony Brook University Hospital, Renaissance School of Medicine at Stony Brook University, Stony Brook, New York, USA.
- Medstar Washington Hospital Center, Georgetown University School of Medicine, Washington, DC, USA.
- UVA Health, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
- Emory University Hospital, Emory University School of Medicine, Atlanta, Georgia, USA.
ORCID-Profile: James W Schurr, Kevin McGowan, Akram Zaaqoq
Zitieren
APA
Schurr, J. W., Ambrosi, L., Fitzgerald, J., Bermudez, C., Genuardi, M. V., Brahier, M., Elliot, T., McGowan, K., Zaaqoq, A., Laskar, S., Pope, S. M., Givertz, M. M., Mallidi, H., Sylvester, K. W., Seifert, F. C., & McLarty, A. J. (2024). Multicenter evaluation of left ventricular assist device implantation with or without ECMO bridge in cardiogenic shock. Artificial Organs, 48(8), 921-931. https://doi.org/10.1111/aor.14740
Vancouver
Schurr JW, Ambrosi L, Fitzgerald J, Bermudez C, Genuardi MV, Brahier M, et al. Multicenter evaluation of left ventricular assist device implantation with or without ECMO bridge in cardiogenic shock. Artificial Organs. 2024;48(8):921-931. doi:10.1111/aor.14740
BibTeX
@article{Schurr2024,
author = {Schurr, James W and Ambrosi, Lara and Fitzgerald, Jillian and Bermudez, Christian and Genuardi, Michael V and Brahier, Mark and Elliot, Tonya and McGowan, Kevin and Zaaqoq, Akram and Laskar, Sonjoy and Pope, Stuart M and Givertz, Michael M and Mallidi, Hari and Sylvester, Katelyn W and Seifert, Frank C and McLarty, Allison J},
title = {Multicenter evaluation of left ventricular assist device implantation with or without ECMO bridge in cardiogenic shock},
journal = {Artificial Organs},
year = {2024},
volume = {48},
number = {8},
pages = {921--931},
doi = {10.1111/aor.14740}
}
EUVIMED